ABEONA THERAPEUTICS INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Abeona Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q2 2024.
  • Abeona Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $224K, a 89.9% decline year-over-year.
  • Abeona Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $711K.
  • Abeona Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $2.94M, a 1987% increase from 2022.
  • Abeona Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $141K.
  • Abeona Therapeutics Inc. annual Nonoperating Income (Expense) for 2017 was $517K, a 74.3% decline from 2016.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $711K $224K -$1.99M -89.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $2.7M $162K -$241K -59.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.94M $214K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 $111K +$130K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.22M +$2.33M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $403K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 -$19K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$118K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q3 2018 $1.26M $497K +$478K +2516% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $786K $314K +$153K +95% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $633K $153K +$116K +314% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $517K $300K +$1.47M Oct 1, 2017 Dec 31, 2017 10-K 2018-03-16
Q3 2017 -$953K $19K -$2.53M -99.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $1.58M $161K +$149K +1242% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.43M $37K -$579K -94% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $2.01M -$1.17M -$5.08M -130% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $7.09M $2.55M +$2.46M +2702% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $4.63M $12K -$2K -14.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $4.63M $616K +$614K +30700% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $4.02M $3.91M +$15.4M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$11.4M $91K +$927K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$12.3M $14K +$11.8M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$24.1M $2K -$467K -99.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$23.6M -$11.5M -$11.1M -2835% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$12.6M -$836K -$1.38M -255% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$11.2M -$11.8M -$15.3M -435% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-14
Q1 2014 $4.14M $469K -$4.12M -89.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $8.25M -$391K -$21.4M -102% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $29.7M $539K +$14.5M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $15.2M $3.52M +$12.7M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $2.57M $4.58M +$8.79M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$6.22M $21M +$19.1M +959% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-26
Q3 2012 -$25.3M -$13.9M -$16M -752% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$9.23M -$9.15M -$10.1M -1025% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $908K -$4.2M -$4.45M -1781% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $5.36M $1.99M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-20
Q3 2011 $2.13M +$12.6M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $989K -$2.74M -73.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $250K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$10.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $3.73M Apr 2, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.